Omalizumab, sold under the trade name Xolair, is a medication originally designed to reduce sensitivity to allergens. It has been used to try to control severe ...
Learn about Xolair (Omalizumab) may treat, uses, dosage, side effects, drug interactions, warnings, patient labeling, reviews, and related medications.
XOLAIR(R)(omalizumab) for subcutaneous use is an injectable prescription medicine ... Do not receive XOLAIR if you are allergic to omalizumab or any of the ...
XOLAIR® (omalizumab) is a treatment for moderate to severe persistent allergic asthma and Chronic Idiopathic Urticaria (CIU) in appropriate patients.
Results: Omalizumab is a monoclonal antibody targeting the high-affinity receptor binding site on human immunoglobulin (Ig)E. Bound IgE is not available for ...
Medscape - Allergic asthma and chronic idiopathic urticaria dosing for Xolair( omalizumab), frequency-based adverse effects, comprehensive interactions, ...
Feb 15, 2015 ... Omalizumab Injection: learn about side effects, dosage, special precautions, and more on MedlinePlus.
May 15, 2017 ... Information about omalizumab (Xolair), an injectable drug prescribed to treat asthma that is not adequately controlled with inhaled steroids.
Jun 22, 2006 ... Clinical Therapeutics from The New England Journal of Medicine — Omalizumab for Asthma.
Jan 27, 2005 ... Results. Omalizumab is a monoclonal antibody targeting the high-affinity receptor binding site on human immunoglobulin (Ig)E. Bound IgE is ...